Diet-And genetically-induced obesity differentially affect the fecal microbiome and metabolome in APC1638N mice

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Pfalzer, Anna C ^a,b   Nesbeth, Paula Dene C ^a,b   Parnell, Laurence D ^a   Iyer, Lakshmanan K ^c   Liu, Zhenhua ^a,b,d   Kane, Anne V ^a,e   Chen, C Y Oliver ^a,b   Tai, Albert K ^c   Bowman, Thomas A ^a   Obin, Martin S ^a,b   Mason, Joel B ^a,b   Greenberg, Andrew S ^a,b   Choi, Sang Woon ^a,f   Selhub, Jacob ^a,b   Paul, Ligi ^a,b   Crott, Jimmy W ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; INTERLEUKIN 1BETA; LEPTIN RECEPTOR; TUMOR NECROSIS FACTOR;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET INDUCED OBESITY; EXPERIMENTAL OBESITY; FECES MICROFLORA; FEMALE; FIRMICUTES; GENE MUTATION; GENETICALLY INDUCED OBESITY; INTESTINE FLORA; MALE; METABOLOME; METABOLOMICS; MOUSE; MOUSE MODEL; NONHUMAN; PARABACTEROIDES DISTASONIS; PROTEOBACTERIA; ADVERSE EFFECTS; ANIMAL; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; FECES; GENETICS; INTESTINE TUMOR; LIPID DIET; METABOLISM; MICROBIOLOGY; MICROFLORA; MUTATION; OBESITY;

ANIMALS; DIET, HIGH-FAT; FECES; FEMALE; INTESTINAL NEOPLASMS; MALE; METABOLOME; MICE; MICROBIOTA; MUTATION; OBESITY; RECEPTORS, LEPTIN;

EID: 84942572279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135758     Document Type: Article

References (50)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104-17. Epub 2014/03/19. doi: 10.3322/caac.21220 PMID: 24639052.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-91. Epub 2004/08/03. doi: 10.1038/nrc1408 nrc1408 [pii]. PMID: 15286738.
3. Flores MB, Rocha GZ, Damas-Souza DM, Osorio-Costa F, Dias MM, Ropelle ER, et al. Obesityinduced increase in tumor necrosis factor-alpha leads to development of colon cancer in mice. Gastroenterology. 2012;143(3):741-53 e1-4. Epub 2012/06/09. S0016-5085 (12) 00811-6 [pii] doi: 10.1053/j. gastro.2012.05.045 PMID: 22677195.
4. Gravaghi C, Bo J, Laperle KM, Quimby F, Kucherlapati R, Edelmann W, et al. Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice. Int J Obes (Lond). 2008;32(11):1716-9. Epub 2008/08/30. doi: ijo2008149 [pii] doi: 10.1038/ijo.2008.149 PMID: 18725892.
5. Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146(2):357-73. Epub 2013/12/10. doi: S0016-5085 (13) 01733-2 [pii] doi: 10.1053/j.gastro.2013.11.051 PMID: 24315827; PubMed Central PMCID: PMC3978703.
6. Yehuda-Shnaidman E, Schwartz B. Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis. Obes Rev. 2012;13(12):1083-95. Epub 2012/09/04. doi: 10.1111/j.1467-789X.2012.01024.x PMID: 22937964.
7. McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013;8(1):e53653. Epub 2013/01/22. doi: 10.1371/journal. pone.0053653 PONE-D-12-16537 [pii]. PMID: 23335968; PubMed Central PMCID: PMC3546075.
8. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010;1(3):138-47. Epub 2010/08/27. doi: 10.4161/gmic.1.3.12360 1949-0976-1-3-4 [pii]. PMID: 20740058; PubMed Central PMCID: PMC2927011.
9. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320-9. Epub 2011/08/19. doi: ismej2011109 [pii] doi: 10.1038/ismej.2011.109 PMID: 21850056; PubMed Central PMCID: PMC3260502.
10. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013;105(24):1907-11. Epub 2013/12/10. doi: djt300 [pii] doi: 10.1093/jnci/djt300 PMID: 24316595; PubMed Central PMCID: PMC3866154.
11. Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio. 2013;4(6):e00692-13. Epub 2013/11/07. doi: mBio.00692-13 [pii] doi: 10.1128/mBio.00692-13 PMID: 24194538; PubMed Central PMCID: PMC3892781.
12. Baxter NT, Zackular JP, Chen GY, Schloss PD. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome. 2014;2:20. Epub 2014/06/27. doi: 10. 1186/2049-2618-2-20 2049-2618-2-20 [pii]. PMID: 24967088; PubMed Central PMCID: PMC4070349.
13. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-31. Epub 2006/12/22. doi: nature05414 [pii] doi: 10.1038/nature05414 PMID: 17183312.
14. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3(4):213-23. Epub 2008/0415. doi: S1931-3128(08)00089-9 [pii] doi: 10.1016/j.chom.2008.02.015 PMID: 18407065; PubMedCentral PMCID: PMC3687783.
15. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587(Pt 17):4153-8. Epub 2009/06/06. doi: jphysiol.2009.174136 [pii] doi: 10.1113/jphysiol.2009.174136 PMID: 19491241; PubMed Central PMCID: PMC2754355.
16. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8. Epub 2011/09/03. doi: science. 1208344 [pii] doi: 10.1126/science.1208344 PMID: 21885731; PubMed Central PMCID: PMC3368382.
17. Fodde R, Edelmann W, Yang K, Van Leeuwen C, Carlson C, Renault B, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA. 1994;91(19):8969-73. PMID: 8090754
18. Liu Z, Ciappio ED, Crott JW, Brooks RS, Nesvet J, Smith DE, et al. Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZxApc1638N mice. FASEB J. 2011;25(9):3136-45. Epub 2011/06/08. doi: fj.11-184143 [pii] doi: 10.1096/fj.11-184143 PMID: 21646397; PubMed Central PMCID: PMC3157689.
19. Huffman DM, Augenlicht LH, Zhang X, Lofrese JJ, Atzmon G, Chamberland JP, et al. Abdominal obesity, independent from caloric intake, accounts for the development of intestinal tumors in Apc (1638N/+) female mice. Cancer Prev Res (Phila). 2013;6(3):177-87. Epub 2013/03/08. doi: 6/3/177 [pii] doi: 10.1158/1940-6207. CAPR-12-0414 PMID: 23466815; PubMed Central PMCID: PMC3595118.
20. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science. 1966;153(3740):1127-8. Epub 1966/09/02. PMID: 5918576.
21. Siegmund B, Lehr HA, Fantuzzi G, Dinarello CA. IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation. P Natl Acad Sci USA. 2001;98(23):13249-54. doi: 10.1073/pnas.231473998 ISI:000172076800075.
22. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, et al. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol. 2009;37(4):521-35. Epub 2009/05/22. doi: 37/4/521 [pii] doi: 10.1177/0192623309336152 PMID: 19458390.
23. Evans AM, De Haven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656-67. Epub 2009/07/25. doi: 10.1021/ac901536h PMID: 19624122.
24. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform. 2010;2(1):9. Epub 2010/10/20. doi: 1758-2946-2-9 [pii] doi: 10. 1186/1758-2946-2-9 PMID: 20955607; PubMed Central PMCID: PMC2984397.
25. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40(Web Server issue):W127-33. Epub 2012/05/04. doi: gks374 [pii] doi: 10.1093/nar/gks374 PMID: 22553367; PubMed Central PMCID: PMC3394314.
26. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4516-22. Epub 2010/06/11. doi: 1000080107 [pii] doi: 10.1073/pnas.1000080107 PMID: 20534432; PubMed Central PMCID: PMC3063599.
27. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335-6. Epub 2010/04/13. doi: nmeth.f.303 [pii] doi: 10.1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
28. De Santis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069-72. Epub 2006/07/06. doi: 72/7/5069 [pii] doi: 10.1128/AEM.03006-05 PMID: 16820507; PubMed Central PMCID: PMC1489311.
29. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. Epub 2011/06/28. doi: gb-2011-12-6-r60 [pii] doi: 10.1186/gb-2011-12-6-r60 PMID: 21702898; PubMed Central PMCID: PMC3218848.
30. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134. Epub 2012/06/20. doi: 1471-2105-13-134 [pii] doi: 10.1186/1471-2105-13-134 PMID: 22708584; PubMed Central PMCID: PMC3412702.
31. R-Core-Team. R: A Language and Environment for Statistical Computing: R Foundation for Statistical Computing; 2013 [cited 2014]. Available from: http://www.R-project.org.
32. Genomics and Bioinformatics Group LoMPL, Center for Cancer Research (CCR) National Cancer Institute (NCI). CIMminer. Available from: http://discover.nci.nih.gov/cimminer/.
33. Mane J, Pedrosa E, Loren V, Ojanguren I, Fluvia L, Cabre E, et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr. 2009;139(3):603-10. Epub 2009/01/08. doi: jn. 108.101170 [pii] doi: 10. 3945/jn. 108.101170 PMID: 19126671.
34. Finucane MM, Sharpton TJ, Laurent TJ, Pollard KS. A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS One. 2014;9(1):e84689. Epub 2014/01/15. doi: 10. 1371/journal.pone.0084689 PONE-D-13-22161 [pii]. PMID: 24416266; PubMed Central PMCID: PMC3885756.
35. Daniel H, Moghaddas Gholami A, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J. 2014;8(2):295-308. Epub 2013/09/14. doi: ismej2013155 [pii] doi: 10.1038/ismej.2013.155 PMID: 24030595; PubMed Central PMCID: PMC3906816.
36. Zitomersky NL, Atkinson BJ, Franklin SW, Mitchell PD, Snapper SB, Comstock LE, et al. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One. 2013;8(6):e63686. Epub 2013/06/19. doi: 10.1371/journal.pone.0063686 PONE-D-12-37300 [pii]. PMID: 23776434; PubMed Central PMCID: PMC3679120.
37. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011;163(2):250-9. Epub 2010/11/23. doi: 10.1111/j.1365-2249.2010.04286.x PMID: 21087444; PubMed Central PMCID: PMC3043316.
38. Antonioli L, Fornai M, Colucci R, Ghisu N, Da Settimo F, Natale G, et al. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther. 2007;322(2):435-42. Epub 2007/05/10. doi: jpet.107.122762 [pii] doi: 10.1124/jpet.107.122762 PMID: 17488880.
39. Brown JB, Lee G, Grimm GR, Barrett TA. Therapeutic benefit of pentostatin in severe IL-10-/-colitis. Inflamm Bowel Dis. 2008;14(7):880-7. Epub 2008/03/15. doi: 10.1002/ibd.20410 PMID: 18340641; PubMed Central PMCID: PMC3065943.
40. Siegmund B, Rieder F, Albrich S, Wolf K, Bidlingmaier C, Firestein GS, et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther. 2001;296(1):99-105. Epub 2000/12/21. PMID: 11123368.
41. Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology. 2005;129(1):26-33. Epub 2005/07/14. doi: S0016508505010322 [pii]. PMID: 16012931.
42. Mabley J, Soriano F, Pacher P, Hasko G, Marton A, Wallace R, et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol. 2003;466(3):323-9. Epub 2003/04/16. doi: S001429990301570X [pii]. PMID: 12694816.
43. Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, et al. The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. J Pharmacol Exp Ther. 2010;335(2):434-42. Epub 2010/07/30. doi: jpet.110.171223 [pii] doi: 10. 1124/jpet.110.171223 PMID: 20668053.
44. Friedman DJ, Kunzli BM, YIA R, Sevigny J, Berberat PO, Enjyoji K, et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci USA. 2009;106(39):16788-93. Epub 2009/10/07. doi: 0902869106 [pii] doi: 10.1073/pnas.0902869106 PMID: 19805374; PubMed Central PMCID: PMC2757811.
45. Frick JS, MacManus CF, Scully M, Glover LE, Eltzschig HK, Colgan SP. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol. 2009;182(8):4957-64. Epub 2009/04/04. doi: 182/8/4957 [pii] doi: 10.4049/jimmunol.0801324 PMID: 19342675; PubMed Central PMCID: PMC2831100.
46. Muller-Haegele S, Muller L, Whiteside TL. Immunoregulatory activity of adenosine and its role in human cancer progression. Expert Rev Clin Immunol. 2014;10(7):897-914. Epub 2014/05/30. doi: 10. 1586/1744666X.2014.915739 PMID: 24871693.
47. Antonioli L, Blandizzi C, Pacher P, Hasko G. Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer. 2013;13(12):842-57. Epub 2013/11/15. doi: nrc3613 [pii] doi: 10.1038/nrc3613 PMID: 24226193.
48. Hausler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Honig A, et al. Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosinedependent immune evasion. Am J Transl Res. 2014;6(2):129-39. Epub 2014/02/04. PMID: 24489992; PubMed Central PMCID: PMC3902223.
49. Burghoff S, Flogel U, Bongardt S, Burkart V, Sell H, Tucci S, et al. Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice. Arch Physiol Biochem. 2013;119(2):39-51. Epub 2013/02/13. doi: 10.3109/13813455.2012.755547 PMID: 23398498.
50. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013;8(8):e70803. Epub 2013/08/14. doi: 10.1371/journal.pone.0070803 PONE-D-13-13993 [pii]. PMID: 23940645; PubMed Central PMCID: PMC3735522.